746304
Last Update Posted: 2008-09-03
Recruiting has ended
All Genders accepted | 1 Day-5 Years |
164 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin
To investigate long-term treatment outcomes of patients receiving botulinum toxin A therapy for infantile and acquired esotropia.
Participants: 164 patients with infantile esotropia and 89 patients with acquired esotropia.
Methods: Patients were injected with botulinum toxin into two medial rectus muscles and followed from 1992 to 2005. Patients were evaluated at 1 week, 2, 6 and 12 months, and then yearly post-injection.
Main Outcome Measures: Degree of motor alignment, recurrence rate, incidence of stereopsis, and dissociated vertical deviation along with complications.
Eligibility
Relevant conditions:
Esotropia
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Data sourced from ClinicalTrials.gov